Home/Filings/4/0000914190-18-000569
4//SEC Filing

PERSEN MALCOLM C 4

Accession 0000914190-18-000569

CIK 0001196298other

Filed

Dec 17, 7:00 PM ET

Accepted

Dec 18, 5:28 PM ET

Size

11.1 KB

Accession

0000914190-18-000569

Insider Transaction Report

Form 4
Period: 2018-12-14
Transactions
  • Award

    Common Stock

    2018-12-14+71,509336,750 total
Holdings
  • Stock Option (Right to Buy)

    Exercise: $0.40Exp: 2026-08-24Common Stock (33,880 underlying)
    33,880
  • Warrants (right to buy)

    (indirect: By Spouse)
    Exercise: $0.85From: 2015-05-12Exp: 2020-05-18Common Stock (15,580 underlying)
    15,580
  • Stock Option (Right to Buy)

    Exercise: $0.79Exp: 2025-05-07Common Stock (56,981 underlying)
    56,981
  • Stock Option (Right to Buy)

    Exercise: $0.50Exp: 2027-12-20Common Stock (40,284 underlying)
    40,284
  • Common Stock

    (indirect: By Spouse)
    31,160
Footnotes (3)
  • [F1]On December 14, 2018, the Company granted 71,509 shares of restricted stock of the Company (the "Restricted Stock") in lieu of cash fees payable to Mr. Persen in respect of his services as a member of the Board of Directors of the Company. The Restricted Stock was granted under the Company's 2015 Equity Incentive Plan (the "2015 Plan"). The Restricted Stock vests 6 months following the grant date.
  • [F2]Fully exercisable.
  • [F3]The option vests as to 13,428 shares on each of 12/20/17, 12/20/18 and 12/20/19.

Issuer

NEPHROS INC

CIK 0001196298

Entity typeother

Related Parties

1
  • filerCIK 0001287975

Filing Metadata

Form type
4
Filed
Dec 17, 7:00 PM ET
Accepted
Dec 18, 5:28 PM ET
Size
11.1 KB